TAS-108
- Generic Name
- TAS-108
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C39H55NO10
- CAS Number
- 229634-97-3
- Unique Ingredient Identifier
- 9B29N23K7E
- Indication
Investigated for use/treatment in breast cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- SRI International
- Target Recruit Count
- 146
- Registration Number
- NCT00166543
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath